Paladin/Fouremm/Chicago/Golf/NBB ... you guys are inside my head. For the life of me I cannot figure out how/why this languishing is allowed to continue, and the CEO is keeping his job and fat paycheck. Any other CEO would be out on his "hind end" with this performance. The difference is that Don is the visionary/godfather of RVX, and must be seen as part/parcel, part of the deal, or has the leverage to maintain his position. We would all like to see a dynamic leader in his place, with connections, experience, and know how for a company in this space and development positioning. We had hoped that Eversana was the ticket for at least some of those things.

How has this company sat on its hands for 3-4 years, after a very narrow miss, a BTD resulting from the data from that narrow miss, and a BoM2 conceptual study that gets rid of the bogey (stroke) and will likely focus on even better combination therapies and end targets?! ... there should have been a race to finance, multiple offers, and a race to get it underway while the ultra valuable patent years are slowly wasting away (each and every one of those patent protected years represents BIG dollars).

And what about our Asian connections with Hepa and Ori? In an area (China) that was ground zero for Covid, and remains in trouble with Covid today? China is an autonomous authoritarian government/society, which could do a trial and EUA ABL in a quick few minutes, especially if dollars and clout are involved for China. What's up with that?

I don't think you need to be smarter than a 5th grader, to figure this out going forward. Something is amiss.

My hope (yeah I know, "hope" is not a good strategy), is that this weird silence and keeping the lights on, on a shoestring, is something better than just pure apathy and ineptitude. And with the substantial growing tax loss credit against future revenues, ABL/BTD, epigenetics library of study ready compounds, market $$$ promise of ABL, how can you not sell RVX for $1-2b minimum? It may not be the goal of $4-8b, but that is still a lot of money, and a refocus to Zenith with plenty of cash.

I would like more than that, I would love $5-10+ pps for my stock (I could retire instantly - "take this job and shove it" style), but I would take $3 and run like a thief in the night, at this point, given the performance of the company and low confidence in leadership and management.  

The reality is that we are just riding in the back of the bus, along for the ride, while Don and the 70% are much more enlightened and much more important ... whever they are going?!

We just have to hope (that word again!) that the 30% goals are aligned with the 70% goals, and they can push this flat tire wheel barrow somewhere that gets the ROI they want, which is hopefully aligned with what we want.

I vote SELL ..... I want $10, would be okay with $5, but would still bounce for $3. Sad.

Rant over, sorry so longgggg ... you guys got me riled up lol ... all good, and glta